Chongqing Pharmaceutical Holdings (000950.SZ): Acceptance of Clinical Trials of Clopidogrel Hydrochloride Tablets

Wisdom Financial APP News, Chongqing Pharmaceutical Holdings (000950.SZ) announced that its subsidiary, Chongqing Pharmaceutical (Group) Co., Ltd. (referred to as "Chongqing Pharmaceutical"), has received a "Notice of Acceptance" issued by the National Medical Products Administration for a drug named: Clopidogrel Hydrochloride Tablets.